Elucidation of the underlying mechanisms of action for Ra-223 will soon expand its clinical utility with respect to improved patient selection and integrated bone-targeted therapies.
Sue-Hwa Lin, PhD
Advertisement
Articles by Sue-Hwa Lin, PhD
Advertisement
Latest Updated Articles
- Radium-223: Optimizing Treatment and Research of Osteoblastic Bone Metastasis
Published: July 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
4
What Were The Most Impactful GU Oncology Data From ESMO 2025?
5
